Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDQ&AD: Addressing Challenges in Alzheimer’s Disease, From Early Identification to New Treatment Considerations

The first in a two-part series, this 0.50-credit, 30-minute CME multiplatform program discusses the importance of early identification of AD and how to detect it early, the pathobiology of AD and potential treatments in development to target this pathology, and current treatment options, including the appropriate use of anti-amyloid monoclonal antibody (mAb) treatment.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form